Results 191 to 200 of about 8,134,109 (313)

Finding novel vulnerabilities of hypomorphic BRCA1 alleles

open access: yesMolecular Oncology, EarlyView.
Synthetic lethality screens performed to identify novel vulnerabilities often model complete gene loss, thereby overlooking patient‐derived hypomorphic mutations. In this study, we have performed genome‐wide CRISPR screens on BRCA1 hypomorphic mutations, showing BRCA1I26A behaves like wild‐type, while BRCA1R1699Q mimics deficiency. Furthermore, we have
Anne Schreuder   +10 more
wiley   +1 more source

<i>LvSlc12A2</i> Is a Negative Growth Regulator in Whiteleg Shrimp, <i>Litopenaeus vannamei</i>. [PDF]

open access: yesAnimals (Basel)
Niu P   +10 more
europepmc   +1 more source

Multi-omics approaches explain the growth-promoting effect of the apocarotenoid growth regulator zaxinone in rice. [PDF]

open access: yesCommun Biol, 2021
Wang JY   +15 more
europepmc   +1 more source

Transforming Growth Factor-β: Master Regulator of the Respiratory System in Health and Disease.

open access: yesAmerican Journal of Respiratory Cell and Molecular Biology, 2016
Y. Aschner, G. Downey
semanticscholar   +1 more source

MITF maintains genome stability in nonmelanocyte lineages

open access: yesMolecular Oncology, EarlyView.
MITF is essential for melanocyte survival and acts as an oncogene in 10%–20% of melanomas. We show that MITF depletion causes genome instability in nonmelanocytic cells, leading to LATS2‐mediated P53 activation, cell cycle arrest, and apoptosis. This study highlights the role of MITF as a genome maintenance factor beyond the melanocyte lineage. Created
Drifa H. Gudmundsdottir   +13 more
wiley   +1 more source

MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes.

open access: yesCell, 1998
Thiennu H. Vu   +8 more
semanticscholar   +1 more source

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy